(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.06%) $79.05
(-0.05%) $1.931
(0.86%) $2 330.90
(0.79%) $26.96
(0.98%) $964.30
(-0.46%) $0.933
(-0.67%) $11.02
(-0.31%) $0.798
(0.06%) $93.51
9.97% $ 3.53
@ $4.87
Wydano: 14 vas. 2024 @ 20:51
Zwrot: -27.52%
Poprzedni sygnał: vas. 14 - 16:33
Poprzedni sygnał:
Zwrot: -1.22 %
Live Chart Being Loaded With Signals
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy...
Stats | |
---|---|
Dzisiejszy wolumen | 506 491 |
Średni wolumen | 834 395 |
Kapitalizacja rynkowa | 185.41M |
EPS | $0 ( 2024-03-28 ) |
Następna data zysków | ( $-1.090 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.710 |
ATR14 | $0.0140 (0.40%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-30 | Baker Bros. Advisors Lp | Buy | 40 000 | Non-Qualified Stock Options (right to buy) |
2023-06-30 | Yang Taiyin | Buy | 40 000 | Stock Option (Right to Buy) |
2023-06-30 | Profusek Robert | Buy | 40 000 | Stock Option (Right to Buy) |
2023-06-30 | Levy Richard S | Buy | 40 000 | Stock Option (Right to Buy) |
2023-06-30 | Dahiyat Bassil I | Buy | 40 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
96.05 |
Last 99 transactions |
Buy: 3 824 931 | Sell: 1 385 823 |
Wolumen Korelacja
Kodiak Sciences Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SONN | 0.914 |
VERU | 0.908 |
VNET | 0.908 |
INFI | 0.906 |
DZSI | 0.903 |
LIVN | 0.902 |
TCX | 0.902 |
RYTM | 0.901 |
PCVX | 0.899 |
FNWB | 0.897 |
10 Najbardziej negatywne korelacje | |
---|---|
TYHT | -0.933 |
AAON | -0.913 |
GSHD | -0.912 |
PLPC | -0.905 |
ZGNX | -0.903 |
CNCE | -0.901 |
LNTH | -0.9 |
CPTA | -0.897 |
LMNR | -0.895 |
ADMS | -0.893 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kodiak Sciences Inc Korelacja - Waluta/Towar
Kodiak Sciences Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-25.95M (0.00 %) |
EPS: | $-4.97 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-25.95M (0.00 %) |
EPS: | $-4.97 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-11.00M (0.00 %) |
EPS: | $6 502.21 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-5.16 |
Financial Reports:
No articles found.
Kodiak Sciences Inc
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej